Baxter, empresa del sector farmacéutico, suma un caso más a su lista de escándalos de corrupción. Ahora se trata de Chile, donde la Fiscalía Nacional Económica (FNE) acusa a la farmacéutica que dirige en México Jaime Alberto Upegui de coludirse con otro laboratorio para adjudicarse en forma coordinada una licitación de suero fisiológico de cloruro de sodio, uno de los insumos más utilizados en los centros de salud. Ambos laboratorios se pusieron de acuerdo para presentar propuestas de venta por arriba de los costos de mercado.
Featured News
Coinbase Sues Three States Over Prediction Market Regulations
Dec 19, 2025 by
CPI
Walmart and PayPal Execs Say Prompts Could Trigger AI-Driven Coordination
Dec 19, 2025 by
CPI
Trump Signals New Openness to Filling Democratic Seats on SEC, CFTC, Easing Frictions Over Crypto Bill
Dec 19, 2025 by
CPI
Mexico Antitrust Authority Closes Android Competition Case After Google Commitments
Dec 18, 2025 by
CPI
LinkedIn Antitrust Settlement Faces Setback in California Court
Dec 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi